{
 "as_of": "2026-11-06",
 "cmr": "fr-cm-kg/XPAR/FR0010331421",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# INNATE PHARMA (Euronext Paris: FR0010331421) — research page\n\nAs of 2026-11-06 · fr-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is INNATE PHARMA, listed on Euronext Paris under ticker FR0010331421. Its ISIN is FR0010331421 and its LEI is 9695002Y8420ZB8HJE29. Its security type is Corporate, its segment is not on the record, and its sector is NAF 72.11Z. Its jurisdiction is France (RCS-registered SA à conseil d'administration (s.a.i.)). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 23 filings across 20 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7 days. The latest filing is dated 2026-11-05 and is of type results, 1 day before the record date of 2026-11-06. The exchange median is 8.0 days of cadence, 15.0 filings and 3 days of latency across 316 issuers. The sector median is 8.5 days of cadence, 20.0 filings and 2.0 days of latency across 24 issuers.\n\n## Auditor\n\nThe auditor of record is not on the record, and the auditor's location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this market's register does not yet carry a lifecycle type map. The halt flag is not set, and the issuer is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable for the client category, because the chapter's orderability section carries no client categories. The rule version is acm-68000/fr/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage for this market is not sealed. No issuer years are sealed, the earliest sealed date for the market is not on the record, and the date the live record began is not on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (identity.exchange)\n- https://recherche-entreprises.api.gouv.fr/search?q=424365336 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.fr-cm-kg.ai/events/XPAR/FR0010331421 (the disclosure lines)\n- https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current (the halt flag)\n- https://mcp.fr-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.fr-cm-kg.ai/record/XPAR/FR0010331421 (the record)\n",
 "market": "FR",
 "node": "fr-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the FR vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "FR",
    "reason": "Width 0 records the annual report link only (ORDER-016: source link, not a read)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "FR",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "FR",
    "state": "not_on_record"
   },
   "changes": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "fr-cm-kg/XPAR/FR0010331421",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 316,
     "median_cadence_gap_days": 8,
     "median_filings": 15,
     "median_latency_days": 3,
     "name": "Euronext Paris"
    },
    "sector": {
     "issuers": 24,
     "median_cadence_gap_days": 8.5,
     "median_filings": 20,
     "median_latency_days": 2,
     "name": "NAF 72.11Z"
    }
   },
   "by_type": {
    "directors_dealings": 8,
    "newswire_release": 10,
    "prospectus": 1,
    "regulatory_filing": 1,
    "results": 3
   },
   "cadence_median_gap_days": 7,
   "filing_days": 20,
   "filings": 23,
   "latency_days": 1,
   "latest": [
    {
     "category": null,
     "date": "2026-11-05",
     "source": "https://www.businesswire.com/news/home/20261104506906/en/Innate-Pharma-Reports-Third-Quarter-2026-Business-and-Financial-Update",
     "title": "Innate Pharma Reports Third Quarter 2026 Business and ...",
     "type": "results"
    },
    {
     "category": null,
     "date": "2026-10-27",
     "source": "https://www.businesswire.com/news/home/20261026687365/en/Innate-Pharma-PACIFIC-9-Phase-3-Trial-Readout-Timing-Updated-to-H1-2027",
     "title": "Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing ...",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-21",
     "source": "https://www.businesswire.com/news/home/20261020303567/en/Innate-Pharma-to-Participate-in-the-Stifel-Healthcare-Conference-and-Jefferies-Global-Healthcare-Conference",
     "title": "Innate Pharma to Participate in the Stifel Healthcare ...",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-09-09",
     "source": "https://www.businesswire.com/news/home/20260909692472/fr",
     "title": "Innate Pharma organise une conférence téléphonique et un ...",
     "type": "newswire_release"
    },
    {
     "category": "DD",
     "date": "2026-08-14",
     "source": "https://bdif.amf-france.org/#/information/2026DD1133657",
     "title": "DeclarationDirigeants [DD]",
     "type": "directors_dealings"
    }
   ],
   "latest_filing_date": "2026-11-05",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.fr-cm-kg.ai/events/XPAR/FR0010331421",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "Euronext Paris"
   },
   "isin": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "confirmed",
    "value": "FR0010331421"
   },
   "jurisdiction": {
    "read_by": "French State company search (recherche-entreprises.api.gouv.fr; INSEE / RNE register data) (nature juridique)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://recherche-entreprises.api.gouv.fr/search?q=424365336",
    "state": "sourced",
    "value": "France (RCS-registered SA à conseil d'administration (s.a.i.))"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN FR0010331421)",
    "state": "sourced",
    "value": "9695002Y8420ZB8HJE29"
   },
   "name": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "INNATE PHARMA"
   },
   "sector": {
    "read_by": "French State company search (recherche-entreprises.api.gouv.fr; INSEE / RNE register data) (activité principale, NAF)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://recherche-entreprises.api.gouv.fr/search?q=424365336",
    "state": "sourced",
    "value": "NAF 72.11Z"
   },
   "security_type": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "FR",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "FR0010331421"
   },
   "website": {
    "market": "FR",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "FR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "FR",
  "node": "fr-cm-kg",
  "numbers_hash": "sha256:d351d546331900bc5a4bd1aaf1d6855b5de0be4bf2aabb940005490781d2fa25",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.fr-cm-kg.ai/book/aio.json",
    "door": "https://mcp.fr-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/fr/mifid-ii-product-governance/r1",
   "section": "fr.aio.v10"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.fr-cm-kg.ai/record/XPAR/FR0010331421",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:d351d546331900bc5a4bd1aaf1d6855b5de0be4bf2aabb940005490781d2fa25",
 "path": "/fr/XPAR/FR0010331421",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is INNATE PHARMA, listed on Euronext Paris under ticker FR0010331421. Its ISIN is FR0010331421 and its LEI is 9695002Y8420ZB8HJE29. Its security type is Corporate, its segment is not on the record, and its sector is NAF 72.11Z. Its jurisdiction is France (RCS-registered SA à conseil d'administration (s.a.i.)). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 23 filings across 20 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7 days. The latest filing is dated 2026-11-05 and is of type results, 1 day before the record date of 2026-11-06. The exchange median is 8.0 days of cadence, 15.0 filings and 3 days of latency across 316 issuers. The sector median is 8.5 days of cadence, 20.0 filings and 2.0 days of latency across 24 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record, and the auditor's location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this market's register does not yet carry a lifecycle type map. The halt flag is not set, and the issuer is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable for the client category, because the chapter's orderability section carries no client categories. The rule version is acm-68000/fr/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations pages read.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage for this market is not sealed. No issuer years are sealed, the earliest sealed date for the market is not on the record, and the date the live record began is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://recherche-entreprises.api.gouv.fr/search?q=424365336"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.fr-cm-kg.ai/events/XPAR/FR0010331421"
  },
  {
   "for": "the halt flag",
   "source": "https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.fr-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.fr-cm-kg.ai/record/XPAR/FR0010331421"
  }
 ],
 "title": "INNATE PHARMA (FR0010331421) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}